Researchers estimated that, globally, three in every 1,000 people carry latent multidrug-resistant tuberculosis, or MDR-TB, with the prevalence being 10 times higher among children younger than 15 ...

However, MDR-TB and XDR-TB success rates remain significantly lower, highlighting the urgent need for new treatment approaches and improved patient support systems.

The target of ending the global TB epidemic by 2035 is achievable, Cimas Health Group doctor Philip Manema believes, if there is commitment to investing in the pillars of the global strategy for ...

Unlike the usual TB, MDR-TB needed more medications and injections for a longer period (though the BMC will soon widely introduce a short regimen called BPaL).

Situation critical - that is where the global fight against Tuberculosis (TB) finds itself at the start of 2025. Millions of people around the world are at risk of contracting and dying of a ...

Consumption, phthisis, the white plague – a killer by any other name, tuberculosis (TB) has stalked humanity since at least the ice age. Today, the disease – passed from those who are actively sick to ...

The rise in multidrug-resistant tuberculosis (MDR-TB) among children is raising global health concerns. Learn about its causes, alarming trends, and the urgent need for action.

The ongoing yearlong outbreak of tuberculosis (TB) in the Kansas City, Kansas, area continues to perplex health authorities, a full year after it began. The TB outbreak has led to 67 active cases ...

Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new ...

The new WHO-approved MDR-TB treatment BPaL(M) offers hope for tuberculosis patients but is already encountering resistance. A global study identified resistant strains and highlighted rapid ...